Perimyocarditis following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report

Keyphrases

• First Dose 100%
• COVID-19 100%
• Healthy Young 100%
• MRNA-1273 Vaccine 100%
• MRNA-1273 100%
• Perimyocarditis 100%
• Adverse Events 66%
• Hospitalization 33%
• Safety Profile 33%
• Aspirin 33%
• Possible Mechanisms 33%
• Myocardial Injury 33%
• One Dose 33%
• Young Males 33%
• Wall Motion Abnormalities 33%
• Elevated Troponin 33%
• Mild Cases 33%
• Pfizer 33%
• US Adults 33%
• Multiple Imaging Modalities 33%
• Hospital Center 33%
• Colchicine 33%
• On-site Monitoring 33%
• Laboratory Analysis 33%
• Pleuritic Chest Pain 33%
• COVID-19 Vaccine 33%
• Emergency Use Authorization 33%
• Moderna 33%
• COVID-19 mRNA Vaccination 33%
• Prior COVID-19 Infection 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 100%
• SARS Coronavirus 100%
• Messenger RNA 100%
• Infection 50%
• Side Effect 50%
• Heart Muscle Injury 50%
• Acetylsalicylic Acid 50%
• Thorax Pain 50%
• Troponin 50%
• Colchicine 50%
• COVID-19 Vaccine 50%

Medicine and Dentistry

• Severe Acute Respiratory Syndrome Coronavirus 2 100%
• COVID-19 100%
• Messenger RNA 100%
• Adverse Event 66%
• Infection 33%
• Clinician 33%
• Acetylsalicylic Acid 33%
• Thorax Pain 33%
• Side Effect 33%
• Heart Muscle Injury 33%
• Troponin 33%
• Case Presentation 33%
• Colchicine 33%
• COVID-19 Vaccine 33%